Colette Meehan
Pediatric Endocrinology · Greensboro, NCNPI 1932424967
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations.
Across 130 payments — averaging $26.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$386
- Ascendis Pharma Endocrinology Inc$317
- Novo Nordisk$244
- Tandem Diabetes Care, Inc.$235
- Insulet Corporation$205
- Kyowa Kirin, Inc.$195
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,45999%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $386 |
| Ascendis Pharma Endocrinology Inc | 10 | $317 |
| Novo Nordisk | 12 | $244 |
| Tandem Diabetes Care, Inc. | 5 | $235 |
| Insulet Corporation | 11 | $205 |
| Kyowa Kirin, Inc. | 4 | $195 |
| Medtronic(2 entities) | 4 | $170 |
| BETA Bionics, Inc. | 2 | $169 |
| Tolmar, Inc. | 7 | $163 |
| Lilly USA, LLC | 6 | $143 |
| Abbott | 5 | $140 |
| Ultragenyx Pharmaceutical Inc. | 2 | $128 |
| Xeris Pharmaceuticals, Inc. | 5 | $96 |
| Azurity Pharmaceuticals, Inc. | 4 | $93 |
| Endo Pharmaceuticals Inc. | 4 | $82 |
| Dexcom, Inc. | 3 | $77 |
| Ferring Pharmaceuticals Inc. | 4 | $71 |
| Neurocrine Biosciences, Inc. | 3 | $66 |
| Arbor Pharmaceuticals, Inc. | 5 | $66 |
| BD | 2 | $62 |
| Rhythm Pharmaceuticals, Inc. | 2 | $53 |
| Sequel Med Tech, LLC | 2 | $51 |
| AstraZeneca | 2 | $51 |
| Pfizer | 2 | $43 |
| Endo USA, Inc. | 2 | $40 |
| Tolmar Pharmaceuticals, Inc. | 2 | $35 |
| Soleno Therapeutics, Inc. | 1 | $23 |
| Lifescan, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Companion Medical, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Aegerion Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$436
- SKYTROFA$125
- CRYSVITA$122
- Minimed 670G System$121
- t-slim insulin pump$102
How this compares
$3,497 in reported general payments places this provider in the 80th percentile of 46 pediatric endocrinology providers in North Carolina.
See all pediatric endocrinology providers in North Carolina →
Other pediatric endocrinology in Greensboro
- Michael BrennanGreensboro$3K
- Jennifer BadikGreensboro$2K
- Susan TuckerGreensboro$171
- Kristina TeutonicoGreensboro$110
- Mark VanderwelCharlotte$42K
- Jennifer LawChapel Hill$40K
- Jakub MieszczakCharlotte$34K
- Nina JainSanford$22K
- Olga GuptaDurham$22K
- Hillary LockemerRaleigh$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.